168 related articles for article (PubMed ID: 16373603)
21. Lp-PLA2 activity and PLA2G7 A379V genotype in patients with diabetes mellitus.
Wootton PT; Stephens JW; Hurel SJ; Durand H; Cooper J; Ninio E; Humphries SE; Talmud PJ
Atherosclerosis; 2006 Nov; 189(1):149-56. PubMed ID: 16438975
[TBL] [Abstract][Full Text] [Related]
22. Lipoprotein-associated phospholipase A2 activity is associated with risk of coronary heart disease and ischemic stroke: the Rotterdam Study.
Oei HH; van der Meer IM; Hofman A; Koudstaal PJ; Stijnen T; Breteler MM; Witteman JC
Circulation; 2005 Feb; 111(5):570-5. PubMed ID: 15699277
[TBL] [Abstract][Full Text] [Related]
23. Association of lipoprotein-associated phospholipase A2 mass with asymptomatic cerebral artery stenosis.
Wang Y; Zhou B; Zhou P; Yao Y; Cui Q; Liu Y; Yang J; Wu S; Zhao X; Zhou Y
J Cell Mol Med; 2018 Apr; 22(4):2329-2336. PubMed ID: 29424477
[TBL] [Abstract][Full Text] [Related]
24. Lipoprotein-associated phospholipase A2 activity and risk of heart failure: The Rotterdam study.
van Vark LC; Kardys I; Bleumink GS; Knetsch AM; Deckers JW; Hofman A; Stricker BH; Witteman JC
Eur Heart J; 2006 Oct; 27(19):2346-52. PubMed ID: 16952920
[TBL] [Abstract][Full Text] [Related]
25. Increased homocysteine and lipoprotein(a) levels highlight systemic atherosclerotic burden in patients with a history of acute coronary syndromes.
Cioni G; Marcucci R; Gori AM; Valente S; Giglioli C; Gensini GF; Abbate R; Boddi M
J Vasc Surg; 2016 Jul; 64(1):163-70. PubMed ID: 27139787
[TBL] [Abstract][Full Text] [Related]
26. Association between Lp-PLA2 and coronary artery disease: focus on its relationship with lipoproteins and markers of inflammation and hemostasis.
Khuseyinova N; Imhof A; Rothenbacher D; Trischler G; Kuelb S; Scharnagl H; Maerz W; Brenner H; Koenig W
Atherosclerosis; 2005 Sep; 182(1):181-8. PubMed ID: 16115490
[TBL] [Abstract][Full Text] [Related]
27. Association of lipoprotein-associated phospholipase A2 levels with coronary artery disease risk factors, angiographic coronary artery disease, and major adverse events at follow-up.
Brilakis ES; McConnell JP; Lennon RJ; Elesber AA; Meyer JG; Berger PB
Eur Heart J; 2005 Jan; 26(2):137-44. PubMed ID: 15618069
[TBL] [Abstract][Full Text] [Related]
28. Community-based statins and advanced carotid plaque: Role of CD163 positive macrophages in lipoprotein-associated phospholipase A
Otsuka F; Zhao X; Trout HH; Qiao Y; Wasserman BA; Nakano M; Macphee CH; Brandt M; Krug-Gourley S; Guo L; Ladich ER; Cheng Q; Davis HR; Finn AV; Virmani R; Kolodgie FD
Atherosclerosis; 2017 Dec; 267():78-89. PubMed ID: 29101839
[TBL] [Abstract][Full Text] [Related]
29. Oxidized phospholipids, lipoprotein(a), lipoprotein-associated phospholipase A2 activity, and 10-year cardiovascular outcomes: prospective results from the Bruneck study.
Kiechl S; Willeit J; Mayr M; Viehweider B; Oberhollenzer M; Kronenberg F; Wiedermann CJ; Oberthaler S; Xu Q; Witztum JL; Tsimikas S
Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1788-95. PubMed ID: 17541022
[TBL] [Abstract][Full Text] [Related]
30. Plasma lipoprotein-associated phospholipase A2 in patients with metabolic syndrome and carotid atherosclerosis.
Gong HP; Du YM; Zhong LN; Dong ZQ; Wang X; Mao YJ; Lu QH
Lipids Health Dis; 2011 Jan; 10():13. PubMed ID: 21247435
[TBL] [Abstract][Full Text] [Related]
31. C-reactive protein is related to extent and progression of coronary and extra-coronary atherosclerosis; results from the Rotterdam study.
Elias-Smale SE; Kardys I; Oudkerk M; Hofman A; Witteman JC
Atherosclerosis; 2007 Dec; 195(2):e195-202. PubMed ID: 17714718
[TBL] [Abstract][Full Text] [Related]
32. Lipoprotein-associated phospholipase A2 is an independent marker for coronary endothelial dysfunction in humans.
Yang EH; McConnell JP; Lennon RJ; Barsness GW; Pumper G; Hartman SJ; Rihal CS; Lerman LO; Lerman A
Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):106-11. PubMed ID: 16239595
[TBL] [Abstract][Full Text] [Related]
33. Prognostic utility of lipoprotein-associated phospholipase A2 for cardiovascular outcomes in patients with stable coronary artery disease.
Sabatine MS; Morrow DA; O'Donoghue M; Jablonksi KA; Rice MM; Solomon S; Rosenberg Y; Domanski MJ; Hsia J;
Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2463-9. PubMed ID: 17766330
[TBL] [Abstract][Full Text] [Related]
34. Lipoprotein-associated phospholipase A2, vascular inflammation and cardiovascular risk prediction.
Sudhir K
Vasc Health Risk Manag; 2006; 2(2):153-6. PubMed ID: 17319459
[TBL] [Abstract][Full Text] [Related]
35. Lipoprotein-associated phospholipase A
Öngen B; Kalkan Uçar S; Levent E; Azarsız E; Koloğlu T; Çoker M; Sözmen E; Sağın FG
Ann Clin Biochem; 2017 Sep; 54(5):539-547. PubMed ID: 27614353
[TBL] [Abstract][Full Text] [Related]
36. Association of lipoprotein-associated phospholipase A2 mass and activity with calcified coronary plaque in young adults: the CARDIA study.
Iribarren C; Gross MD; Darbinian JA; Jacobs DR; Sidney S; Loria CM
Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):216-21. PubMed ID: 15499045
[TBL] [Abstract][Full Text] [Related]
37. High lipoprotein-associated phospholipase A2 is a risk factor for recurrent coronary events in postinfarction patients.
Corsetti JP; Rainwater DL; Moss AJ; Zareba W; Sparks CE
Clin Chem; 2006 Jul; 52(7):1331-8. PubMed ID: 16709622
[TBL] [Abstract][Full Text] [Related]
38. Lipoprotein-associated phospholipase A2 (Lp-PLA2) and tumor necrosis factor-alpha (TNF-α) and their relation to premature atherosclerosis in β-thalassemia children.
Ragab SM; Safan MA; Obeid OM; Sherief AS
Hematology; 2015 May; 20(4):228-38. PubMed ID: 25056687
[TBL] [Abstract][Full Text] [Related]
39. Analysis of intima-media thickness of carotid artery and lipoprotein-associated phospholipase A2 in coronary heart diseases of different types.
Li Y
Technol Health Care; 2015; 23 Suppl 1():S147-50. PubMed ID: 26410317
[TBL] [Abstract][Full Text] [Related]
40. [Changes of serum lipoprotein-related phospholipase A2 in patients with white matter lesion based on KIM classification and its correlation with carotid atherosclerotic plaque].
Zhang W; Zhang YM; Li LL; Xia Y; Zhou X; Zhu XQ; Sun ZW
Zhonghua Yi Xue Za Zhi; 2020 Apr; 100(15):1130-1135. PubMed ID: 32311875
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
